Goldman Sachs
AXLA

Goldman Sachs’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Goldman Sachs’s Portfolio AXLA Stock Details AXLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-998
Closed -$138K – 5599
2020
Q2 		$138K Buy
+998
New +$122K ﹤0.01% 4906

Other funds holding AXLA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs's AXLA Position: Q3 2020 in Review

Goldman Sachs sold out of Axcella Health Inc. Common Stock (AXLA) in Q3 2020, closing a stake of 998 shares — an estimated $138K sold.

Goldman Sachs first reported a position in AXLA in Q2 2020 and held it in 1 quarter. The position peaked at $138K in Q2 2020. 42 funds tracked by Wall St. Rank hold AXLA as of Q3 2020.

  • Goldman Sachs reported no remaining Axcella Health Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Goldman Sachs sold 998 Axcella Health Inc. Common Stock shares in Q3 2020, an estimated $138K.
  • Goldman Sachs first reported a position in Axcella Health Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Goldman Sachs's Axcella Health Inc. Common Stock position peaked at $138K in Q2 2020.
  • 42 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q3 2020.

Based on Goldman Sachs's 13F filing for Q3 2020, filed 13 Nov 2020.